SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 17th, 2020 • Seelos Therapeutics, Inc. • Pharmaceutical preparations • New York
This Securities Purchase Agreement (as amended, supplemented, restated and/or modified from time to time, this "Agreement") is entered into as of December 11, 2020, by and between Seelos Therapeutics, Inc., a Nevada corporation (the "Company"), and Lind Global Asset Management II, LLC, a Delaware limited liability company (the "Investor").
SEELOS THERAPEUTICS, INC. Form of Convertible Promissory Note due December 11, 2022Convertible Note • December 17th, 2020 • Seelos Therapeutics, Inc. • Pharmaceutical preparations • New York
For value received, SEELOS THERAPEUTICS, INC., a Nevada corporation (the "Maker" or the "Company"), hereby promises to pay to the order of Lind Global Asset Management II, LLC, a Delaware limited liability company (together with its successors and representatives, the "Holder"), in accordance with the terms hereinafter provided, the principal amount of TWELVE MILLION DOLLARS ($12,000,000.00) (the "Principal Amount").
SECURITY AGREEMENTSecurity Agreement • December 17th, 2020 • Seelos Therapeutics, Inc. • Pharmaceutical preparations • New York
SECURITY AGREEMENT (this "Agreement"), dated as of December 11, 2020, by and between SEELOS THERAPEUTICS, INC., a Nevada corporation (the "Company") and LIND GLOBAL ASSET MANAGEMENT II, LLC (the "Secured Party").
